gada

insulin ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33106256 Plasma Metabolome and Circulating Vitamins Stratified Onset Age of an Initial Islet Autoantibody and Progression to Type 1 Diabetes: The TEDDY Study. 2021 Jan 1
2 34272582 Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes. 2021 Sep 2
3 32321876 Efficacy and safety of stem cells transplantation in patients with type 1 diabetes mellitus-a systematic review and meta-analysis. 2020 Aug 28 1
4 30352895 A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy. 2019 Feb 3
5 27760891 Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state. 2017 Feb 27 1
6 29040050 Latent Autoimmune Diabetes in Adults in North Indian Region: Assessment of β-Cell Function, Metabolic and Immunological Features. 2017 Dec 1
7 30603242 Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM). 2016 Mar 1
8 25213702 High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7). 2014 Dec 4
9 23248199 Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. 2013 Apr 1
10 21529979 Experience of the introduction of routine antibody testing in primary care and of running a trial for latent autoimmune diabetes in adults (LADA). 2011 Jul 1
11 21957594 GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles. 2011 1
12 19864397 GAD antibody positivity predicts type 2 diabetes in an adult population. 2010 Feb 2
13 19525594 Pioglitazone might prevent the progression of slowly progressive type 1 diabetes. 2009 1
14 18083788 Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. 2008 Mar 1
15 18438542 [Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?]. 2008 Mar 2
16 16963012 Development of 2 alternative enzyme-linked immunosorbent assays for routine screening of glutamic acid decarboxylase autoantibodies. 2007 Feb 1
17 17435855 Latent autoimmune diabetes in adults (LADA): usefulness of anti-GAD antibody titers and benefit of early insulinization. 2007 Feb 2
18 17461431 Insulin VNTR I/III genotype is associated with autoantibodies against glutamic acid decarboxylase in newly diagnosed type 1 diabetes. 2007 Oct 1
19 16839848 Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea. 2006 Aug 2
20 16061833 Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults. 2005 Aug 4
21 12593469 C-peptide and autoimmune markers in diabetes. 2003 1
22 14679093 Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report. 2003 Nov 1
23 11918625 Clinical characteristics, GAD antibody (GADA) and change of C-peptide in Korean young age of onset diabetic patients. 2002 Mar 1
24 12369720 Islet cell antibodies represent autoimmune response against several antigens. 2001 1
25 11114103 Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds. 2000 Nov-Dec 2
26 11151756 Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. 2000 Dec 1
27 10097919 Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes. 1999 Mar 4